The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pimozide Tablet Market Research Report 2025
Synopsis
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide Tablet market was valued at US$ 1411 million in 2023 and is anticipated to reach US$ 2195.5 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The Pimozide Tablet market has evolved as a prescription medication used to treat various psychiatric disorders, including schizophrenia and Tourette's syndrome. Pimozide is an antipsychotic medication that helps regulate certain chemicals in the brain to alleviate symptoms such as hallucinations, delusions, and repetitive behaviors. Despite being effective in managing these conditions, its use is limited due to potential side effects and interactions with other medications. As psychiatric treatment advances, the Pimozide Tablet market addresses specific medical needs, offering healthcare professionals a tool to address certain mental health disorders while carefully considering individual patient profiles and potential risks.
This report aims to provide a comprehensive presentation of the global market for Pimozide Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide Tablet.
Report Scope
The Pimozide Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pimozide Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pimozide Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pimozide Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pimozide Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
The global Pimozide Tablet market was valued at US$ 1411 million in 2023 and is anticipated to reach US$ 2195.5 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.
The Pimozide Tablet market has evolved as a prescription medication used to treat various psychiatric disorders, including schizophrenia and Tourette's syndrome. Pimozide is an antipsychotic medication that helps regulate certain chemicals in the brain to alleviate symptoms such as hallucinations, delusions, and repetitive behaviors. Despite being effective in managing these conditions, its use is limited due to potential side effects and interactions with other medications. As psychiatric treatment advances, the Pimozide Tablet market addresses specific medical needs, offering healthcare professionals a tool to address certain mental health disorders while carefully considering individual patient profiles and potential risks.
This report aims to provide a comprehensive presentation of the global market for Pimozide Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pimozide Tablet.
Report Scope
The Pimozide Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pimozide Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pimozide Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Par Pharmaceutical
Johnson & Johnson
Eumedica
Pharmascience
Domina Pharmaceuticals
Aa Pharma
Segment by Type
1Mg
2Mg
4Mg
Segment by Application
Hospitals
Drugstores
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pimozide Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pimozide Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pimozide Tablet Market Overview
1.1 Product Overview and Scope of Pimozide Tablet
1.2 Pimozide Tablet Segment by Type
1.2.1 Global Pimozide Tablet Market Value Comparison by Type (2024-2030)
1.2.2 1Mg
1.2.3 2Mg
1.2.4 4Mg
1.3 Pimozide Tablet Segment by Application
1.3.1 Global Pimozide Tablet Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Pimozide Tablet Market Size Estimates and Forecasts
1.4.1 Global Pimozide Tablet Revenue 2019-2030
1.4.2 Global Pimozide Tablet Sales 2019-2030
1.4.3 Global Pimozide Tablet Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pimozide Tablet Market Competition by Manufacturers
2.1 Global Pimozide Tablet Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pimozide Tablet Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pimozide Tablet Average Price by Manufacturers (2019-2024)
2.4 Global Pimozide Tablet Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pimozide Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pimozide Tablet, Product Type & Application
2.7 Pimozide Tablet Market Competitive Situation and Trends
2.7.1 Pimozide Tablet Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pimozide Tablet Players Market Share by Revenue
2.7.3 Global Pimozide Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pimozide Tablet Retrospective Market Scenario by Region
3.1 Global Pimozide Tablet Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pimozide Tablet Global Pimozide Tablet Sales by Region: 2019-2030
3.2.1 Global Pimozide Tablet Sales by Region: 2019-2024
3.2.2 Global Pimozide Tablet Sales by Region: 2025-2030
3.3 Global Pimozide Tablet Global Pimozide Tablet Revenue by Region: 2019-2030
3.3.1 Global Pimozide Tablet Revenue by Region: 2019-2024
3.3.2 Global Pimozide Tablet Revenue by Region: 2025-2030
3.4 North America Pimozide Tablet Market Facts & Figures by Country
3.4.1 North America Pimozide Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pimozide Tablet Sales by Country (2019-2030)
3.4.3 North America Pimozide Tablet Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pimozide Tablet Market Facts & Figures by Country
3.5.1 Europe Pimozide Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pimozide Tablet Sales by Country (2019-2030)
3.5.3 Europe Pimozide Tablet Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pimozide Tablet Market Facts & Figures by Country
3.6.1 Asia Pacific Pimozide Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pimozide Tablet Sales by Country (2019-2030)
3.6.3 Asia Pacific Pimozide Tablet Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pimozide Tablet Market Facts & Figures by Country
3.7.1 Latin America Pimozide Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pimozide Tablet Sales by Country (2019-2030)
3.7.3 Latin America Pimozide Tablet Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pimozide Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Pimozide Tablet Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pimozide Tablet Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pimozide Tablet Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pimozide Tablet Sales by Type (2019-2030)
4.1.1 Global Pimozide Tablet Sales by Type (2019-2024)
4.1.2 Global Pimozide Tablet Sales by Type (2025-2030)
4.1.3 Global Pimozide Tablet Sales Market Share by Type (2019-2030)
4.2 Global Pimozide Tablet Revenue by Type (2019-2030)
4.2.1 Global Pimozide Tablet Revenue by Type (2019-2024)
4.2.2 Global Pimozide Tablet Revenue by Type (2025-2030)
4.2.3 Global Pimozide Tablet Revenue Market Share by Type (2019-2030)
4.3 Global Pimozide Tablet Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pimozide Tablet Sales by Application (2019-2030)
5.1.1 Global Pimozide Tablet Sales by Application (2019-2024)
5.1.2 Global Pimozide Tablet Sales by Application (2025-2030)
5.1.3 Global Pimozide Tablet Sales Market Share by Application (2019-2030)
5.2 Global Pimozide Tablet Revenue by Application (2019-2030)
5.2.1 Global Pimozide Tablet Revenue by Application (2019-2024)
5.2.2 Global Pimozide Tablet Revenue by Application (2025-2030)
5.2.3 Global Pimozide Tablet Revenue Market Share by Application (2019-2030)
5.3 Global Pimozide Tablet Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Pimozide Tablet Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Par Pharmaceutical
6.2.1 Par Pharmaceutical Corporation Information
6.2.2 Par Pharmaceutical Description and Business Overview
6.2.3 Par Pharmaceutical Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Par Pharmaceutical Pimozide Tablet Product Portfolio
6.2.5 Par Pharmaceutical Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Pimozide Tablet Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Eumedica
6.4.1 Eumedica Corporation Information
6.4.2 Eumedica Description and Business Overview
6.4.3 Eumedica Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eumedica Pimozide Tablet Product Portfolio
6.4.5 Eumedica Recent Developments/Updates
6.5 Pharmascience
6.5.1 Pharmascience Corporation Information
6.5.2 Pharmascience Description and Business Overview
6.5.3 Pharmascience Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pharmascience Pimozide Tablet Product Portfolio
6.5.5 Pharmascience Recent Developments/Updates
6.6 Domina Pharmaceuticals
6.6.1 Domina Pharmaceuticals Corporation Information
6.6.2 Domina Pharmaceuticals Description and Business Overview
6.6.3 Domina Pharmaceuticals Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Domina Pharmaceuticals Pimozide Tablet Product Portfolio
6.6.5 Domina Pharmaceuticals Recent Developments/Updates
6.7 Aa Pharma
6.6.1 Aa Pharma Corporation Information
6.6.2 Aa Pharma Description and Business Overview
6.6.3 Aa Pharma Pimozide Tablet Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aa Pharma Pimozide Tablet Product Portfolio
6.7.5 Aa Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pimozide Tablet Industry Chain Analysis
7.2 Pimozide Tablet Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pimozide Tablet Production Mode & Process
7.4 Pimozide Tablet Sales and Marketing
7.4.1 Pimozide Tablet Sales Channels
7.4.2 Pimozide Tablet Distributors
7.5 Pimozide Tablet Customers
8 Pimozide Tablet Market Dynamics
8.1 Pimozide Tablet Industry Trends
8.2 Pimozide Tablet Market Drivers
8.3 Pimozide Tablet Market Challenges
8.4 Pimozide Tablet Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
